GOGo Okada

Go Okada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Go Okada has a total of 527 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Insula–cerebellar functional connectivity associated with somatic symptoms in mood disorders: Differential patterns and longitudinal evidence in major depressive disorder

    by Shin Hattori, Toshiharu Kamishikiryo, Alan S. R. Fermin, Yoichiro Matsumoto, Yuki Mitsuyama, Eri Itai, Yoshikazu Masuda, Go Okada

    Aim: This study aimed to identify the resting‐state functional connectivity (rsFC) of insula subregions associated with nonspecific somatic symptoms in mood disorders and to examine whether these connections are state‐dependent. Methods: In Phase 1, seed‐based rsFC analyses were performed using 12 insula subregions from the Brainnetome Atlas in patients with major depressive disorder (MDD), bipolar disorder (BD), and healthy controls. Associations between rsFC and the somatic factor of the Beck Depression Inventory‐II (BDI_S) were examined in each group. In Phase 2, insula connections significantly associated with BDI_S in the MDD group were selected as regions of interest, and longitudinal changes in rsFC over 6 weeks were tested for associations with changes in BDI_S. Results: In Phase 1, rsFC between several insular subregions and the left cerebellar lobule VIII (Cereb 8_L) showed modest negative correlations with BDI_S in the MDD group, while rsFC involving the right superior lateral occipital cortex or Cereb 8_L showed positive correlations in the BD group. In MDD and BD, the rsFC between the right dorsal granular insula (dIg_R) and Cereb 8_L showed opposite relationships with BDI_S in the cross‐sectional analysis. In Phase 2, increases in dIg_R–Cereb 8_L were significantly associated with reductions in BDI_S in MDD with a modest effect size. Conclusion: Insula–cerebellum rsFC, particularly between dIg_R and Cereb 8_L, may serve as a potential state‐related neural correlate of nonspecific somatic symptoms in MDD, with potentially distinct functional roles in MDD versus BD.


  • Open Access

    Harmonizing Depression Severity Across Mood Disorders in the ENIGMA Consortium: An Item Response Theory Mega-analysis of Brain Structure

    by Emma Corley, John O’COnnor, Giulia Tronchin, Shir Dahan, Andrea Fernandes, Mia Casburn, Zuzanna Wisniewska, Leila Nabulsi, Genevieve McPhilemy, Fiona Martyn, et al.

    Background: Depressive symptoms cut across bipolar disorder (BD) and major depressive disorder (MDD), yet the extent to which the neurobiology of depressive severity is shared or diagnosis-specific is not well established. Progress is limited because multisite studies pool data from different depression rating scales, obscuring symptom-brain relationships. We used item response theory (IRT), which places these instruments on a single metric, to harmonise depressive symptom severity across five rating scales, and to identify shared and disorder-specific brain correlates of depression across BD and MDD.Methods: This cross-sectional mega-analysis of individual participant data from 52 international ENIGMA MDD and BD Working Group sites studied 11 999 individuals (6,789 healthy controls, 3,307 with BD, 1,903 with MDD) who had completed a depression measure and undergone T1-weighted MRI. We derived general and five symptom-specific IRT scores harmonised across five instruments (HDRS, MADRS, BDI-II, IDS, CES-D), and related them to cortical thickness, surface area, and subcortical volume, adjusting for age, sex, and global brain measures.Findings: Harmonising symptom scores strengthened brain-symptom associations beyond unharmonised total scores. Higher general depression severity was linked to lower cortical thickness, which strengthened after accounting for BD-MDD item-level differences. The disorders diverged: depressive severity was more tightly linked to subcortical structure, especially the hippocampus and thalamus, in MDD than BD, while BD showed lower cortical thickness across a wider cortical extent and more heterogeneous structural variability. Symptom dimensions diverged too: mood/motivational symptoms tracked cortical thickness in both disorders, while anxiety, cognitive-affective, and suicidal-ideation symptoms showed more disorder-specific subcortical and surface-area patterns.Interpretation: IRT harmonisation identified overlapping and disorder-specific associations between depressive severity and brain structure in BD and MDD, highlighting shared neurobiological features while demonstrating meaningful differences between disorders and supporting global efforts to integrate dimensional symptom measures across large-scale, multiscale studies.Funding: This work was supported by the US National Institute of Mental Health (R0I MH129742), including subaward SCON-00003343 awarded to Colm McDonald and Dara Cannon.

  • Open Access

    In memoriam: Professor Shigeto Yamawaki (January 15, 1954–June 8, 2026)—a visionary leader connecting Japan, Asia, and the world

    by Kazutaka Ikeda, Gabriella Gobbi, Joseph Zohar, Gregers Wegener, Pierre Blier, Siegfried Kasper, John H Krystal, Anthony Phillips, Hans-Jürgen Möller, Toshikazu Saito, et al.

  • Open Access

    Decomposing neuroanatomical heterogeneity in depression: insights from an ENIGMA major depressive disorder working group study in 5146 individuals

    by Lukas Sempach, Sarah Ulrich, Stéphanie E. E. C. Bauduin, Jochen Bauer, Francesco Benedetti, Klaus Berger, Bianca Besteher, Robin Bülow, Colm G. Connolly, Emmanuelle Corruble, et al.

    The clinical and biological heterogeneity of major depressive disorder (MDD) may reflect the aggregation of different conditions with distinct pathologies under a single diagnostic label. Neuroanatomical heterogeneity in MDD was examined using a harmonized, age- and sex-matched sample from the ENIGMA MDD consortium (N = 5146; age range: 9–82 years; 64% female). Analyses of global neurostrucutral variability revealed greater cortical thickness heterogeneity in MDD compared with healthy controls (Cohen’s d = –0.26). Regionally, increased variability in cortical thickness was most prominent in the cingulate (+6.1 to +6.6% more variation in MDD) and insular (+5.8%) cortices, as well as in the frontal (+5.7 to +6.8%) and temporal (+6.1 to +6.8%) lobes. Heterogeneity in cortical thickness was more pronounced among patients using antidepressant medication (Cohen’s d = –0.39). Patient-specific analyses further showed that individuals with markedly increased cortical thickness variability (th percentile relative to the normative range) exhibited greater depressive symptom severity than those within the normative range (5 th –95 th percentile; Cohen’s d = 0.19–0.36). Overall, the results indicate that neuroanatomical heterogeneity in MDD is primarily expressed in cortical thickness, offering refined insights into the neurobiological complexity of structural alterations associated with depression. These findings could guide future stratification efforts examining whether regionally confined changes in cortical thickness within areas of pronounced variability reflect clinically meaningful patient subgroups.

  • Vertex-wise cortical abnormalities in major depressive disorder from 64 cohorts from the DIRECT and ENIGMA MDD consortia

    by Chao-Gan Yan, Zi-Han Wang, Laura K. M. Han, Nina Alexander, Dag Alnæs, Zeynep Başgöze, Stéphanie E. E. C. Bauduin, Jochen Bauer, Francesco Benedetti, Klaus Berger, et al.


  • Open Access

    Activation of the Anterior Insular and Prefrontal Cortices During Attention Switching and Task Execution: A Study Using a Cued-Switching Task and Functional Magnetic Resonance Imaging

    by Miyuki Kato, Shigeyuki Kan, Naho Ichikawa, Masahiro Takamura, Go Okada

    Background: It is more difficult to concentrate when switching attention from rest to a task than when performing a task continuously. The anterior insular cortex (AIC) plays a role in the mechanisms underlying attention disorders such as attention deficit hyperactivity disorder. The AIC is activated by cues that demand attentional switching; however, it is unclear whether this activity correlates with performance. Furthermore, it is not clear whether the AIC is important during task execution as well as task preparation. Purpose: This study examined the role of the AIC in attentional switching. Research Design: In this study, we created a shortened version of the cued-switching task, which is a cognitive test that assesses the maintenance of focus during task repetition and refocusing on a task after an unexpected interruption or short rest, and assessed brain activity during the task using functional magnetic resonance imaging. Study Sample: Thirty-two healthy adults participated in the study. Data Collection and/or Analysis: We measured brain activity and analyzed its relation to network activity and reaction time. Results: The results revealed that the AIC was also important during task execution and was active together with the prefrontal cortex. AIC activity promoted activity in the salience network, prefrontal cortex, and motor areas. Furthermore, AIC activity during task execution was negatively correlated with reaction time in the absence of attentional switching. Conclusions: These findings suggest that AIC activity is important for switching attention and for completing tasks with or without attentional switching. This study shows the possibility of the AIC becoming an effective target for attention training in the future.

  • Open Access

    Identifying Physiological and Cognitive Indicators of Subthreshold Depression and Major Depressive Disorder Progression Risk

    by Ayaka Shimizu, Satoshi Yokoyama, Alan Sr Fermin, Yuki Mitsuyama, Keisuke Mizoi, Junichiro Yoshimoto, Toshi Furukawa, Koki Takagaki, Yuri Okamoto, Yasumasa Okamoto, et al.

    Purpose: Subthreshold depression (StD), depressive symptoms below the diagnostic threshold for major depressive disorder (MDD), is associated with functional impairment and increased risk of MDD onset, but its physiological and cognitive characteristics remain unclear. This study aimed to identify objective markers of StD and validate predictive factors for MDD onset. Patients and Methods: Among 168 university students, participants were classified into a StD group (n=87) and a healthy control group (n=81) using the Beck Depression Inventory-II (BDI-II). The StD group was further subdivided into “low depression” (BDI-II < 10, n = 21) and “maintained depression” (BDI-II ≥ 10, n = 66) based on their BDI-II scores at baseline. Assessments included voice characteristics, heart rate variability (HRV), peripheral body temperature, emotion recognition, and neurocognitive tasks. Between-group differences were tested using ANOVA and MANOVA, and participants were followed for MDD onset at 3-month intervals until March 2024. Results: Compared to controls, the StD group showed increased vocal arousal (p = 0.007), elevated peripheral body temperature (p < 0.001), and reduced low-frequency HRV (p = 0.018). Sustained attention and executive function were impaired (p < 0.05). Accuracy in emotion recognition was lower for happy and surprised expressions (p = 0.030; p = 0.038). Subgroup analysis revealed more pronounced impairments in HRV, executive function, and emotion recognition in the maintained depression subgroup, which also had a higher MDD incidence (7 cases). In contrast, the low depression group showed selective attentional deficits and impaired emotion recognition, but no MDD onset. Conclusion: StD correlates with physiological and cognitive abnormalities reflecting MDD, and persistent symptoms suggest increased progression risk. These findings present candidate markers (voice arousal, HRV, body temperature, emotion recognition) for early identification and risk stratification; however, conclusions should be interpreted cautiously given the exploratory design.


  • Open Access

    Relationship between hippocampal volume and treatment response before and after escitalopram administration in patients with depression

    by Toshiharu Kamishikiryo, Eri Itai, Yuki Mitsuyama, Yoshikazu Masuda, Osamu Yamamoto, Tatsuji Tamura, Hiroaki Jitsuiki, Akio Mantani, Norio Yokota, Go Okada

    The hippocampus plays a crucial role in memory formation and emotional regulation, and is closely related to the pathology of depression. Escitalopram, a selective serotonin reuptake inhibitor, promotes neurogenesis in the dentate gyrus of the hippocampus and alters its structure. This study examined the relationship between these escitalopram-induced structural changes and treatment response in 107 patients with moderate to severe depression, of whom 56 were female (52.3%), with a mean age of 41.5 years (range: 25–73 years). Follow-up data were available for 71 patients (66.4%). Changes in the volume and laterality of hippocampal subregions were compared before and after escitalopram treatment between Responders to escitalopram ( n = 53) and Nonresponders ( n = 54). The results indicated that Responders had a larger left hippocampal volume (β = 189.3, 95% CI [71.4, 307.2], Cohen’s f² ≈ 0.094) and greater leftward laterality (β = 0.012, 95% CI [2.2 × 10⁻⁴, 0.024], Cohen’s f² ≈ 0.04) than Nonresponders at baseline. Additionally, the right hippocampus and right hippocampal head exhibited increased volume (β = 80.6, 95% CI [28.5, 132.8], Cohen’s f² ≈ 0.005; β = 50.4, 95% CI [22.2, 78.5], Cohen’s f² ≈ 0.006) and altered laterality (β = −0.011, 95% CI [−0.022, −4.1 × 10⁻⁴], Cohen’s f² ≈ 0.003; β = −3.3 × 10⁻⁴, 95% CI [−5.7 × 10⁻⁴, −8.3 × 10⁻⁵], Cohen’s f² ≈ 0.006) in response to escitalopram in Responders compared to Nonresponders. Furthermore, the volume changes in the right hippocampus and right hippocampal head correlated with core depressive symptoms. It is suggested that these volume changes play an important role in the improvement of core symptoms of depression by escitalopram treatment. These findings can help to reveal the mechanisms of action of selective serotonin reuptake inhibitors and have the potential to facilitate the early identification of patients who will respond to treatment.


  • Open Access

    Comprehensive evaluation of pipelines for classification of psychiatric disorders using multi-site resting-state fMRI datasets

    by Yuji Takahara, Yuto Kashiwagi, Tomoki Tokuda, Junichiro Yoshimoto, Yuki Sakai, Ayumu Yamashita, Toshinori Yoshioka, Hidehiko Takahashi, Hiroto Mizuta, Kiyoto Kasai, et al.


  • Open Access

    The status of MRI databases across the world focused on psychiatric and neurological disorders

    by Saori C. Tanaka, Kiyoto Kasai, Yasumasa Okamoto, Shinsuke Koike, Takuya Hayashi, Ayumu Yamashita, Okito Yamashita, Tom Johnstone, Franco Pestilli, Kenji Doya, et al.

    Neuroimaging databases for neuro‐psychiatric disorders enable researchers to implement data‐driven research approaches by providing access to rich data that can be used to study disease, build and validate machine learning models, and even redefine disease spectra. The importance of sharing large, multi‐center, multi‐disorder databases has gradually been recognized in order to truly translate brain imaging knowledge into real‐world clinical practice. Here, we review MRI databases that share data globally to serve multiple psychiatric or neurological disorders. We found 42 datasets consisting of 23,293 samples from patients with psychiatry and neurological disorders and healthy controls; 1245 samples from mood disorders (major depressive disorder and bipolar disorder), 2015 samples from developmental disorders (autism spectrum disorder, attention‐deficit hyperactivity disorder), 675 samples from schizophrenia, 1194 samples from Parkinson's disease, 5865 samples from dementia (including Alzheimer's disease), We recognize that large, multi‐center databases should include governance processes that allow data to be shared across national boundaries. Addressing technical and regulatory issues of existing databases can lead to better design and implementation and improve data access for the research community. The current trend toward the development of shareable MRI databases will contribute to a better understanding of the pathophysiology, diagnosis and assessment, and development of early interventions for neuropsychiatric disorders.